Cancer Research and Treatments

SEP 9, 2026 · JOURNAL ARTICLE

A Manganese-Chlorella Hydrogel for an Integrated “Remove–Remodel–Repair” Strategy in Pancreatic Cancer Therapy

Nano-micro Letters

This is a preclinical proof-of-concept study of a novel hydrogel material tested in vitro and in animal models, demonstrating feasibility but lacking human clinical data or comparison to standard therapy.

SEP 8, 2026 · JOURNAL ARTICLE

mRNA therapeutics in cancer: from molecular design to clinical translation

Molecular Cancer

A comprehensive review synthesizing the state of mRNA cancer therapeutics across design, delivery, and clinical translation—expert framing rather than a new empirical finding.

SEP 8, 2026 · JOURNAL ARTICLE

Targeted protein degradation dismantles undruggable targets to reverse immune evasion and therapy resistance in cancer

Frontiers in Immunology

A comprehensive review summarizing molecular principles, clinical progress, and translational strategies for targeted protein degradation in cancer immunotherapy, rather than reporting original experimental data or trial results.

SEP 8, 2026 · JOURNAL ARTICLE

Gut Microbiome Control of Tumor Immune Checkpoint Inhibitor Response: Mechanistic Insights and Clinical Translation

Theoretical and Natural Science

This is a mechanistic review summarizing proposed pathways by which microbiota may influence ICI response, raising questions for future investigation rather than reporting a primary empirical result or clinical trial outcome.

SEP 8, 2026 · JOURNAL ARTICLE

Engineering probiotic consortia to improve chemotherapy tolerance and reduce toxicity in breast cancer patients: a new frontier in supportive precision oncology

Oncology Reviews

This is a narrative review synthesizing mechanistic rationale and emerging evidence for a novel intervention; it raises questions about engineered probiotic consortia rather than reporting definitive efficacy data from controlled trials.

SEP 7, 2026 · JOURNAL ARTICLE

Long-term exposure of Lactobacillus rhamnosus to quercetin enhances its anti-angiogenic and anti-colorectal cancer efficacy

Scientific Reports

In vitro mechanistic study demonstrating enhanced probiotic metabolite activity against colorectal cancer cells and angiogenesis, but lacking in vivo efficacy data, clinical endpoints, or human translation.

SEP 7, 2026 · JOURNAL ARTICLE

Reprogramming the Tumor Microenvironment and Cancer Therapy via Nanocatalytic Medicine

Acs Nano Medicine

A narrative review proposing nanocatalytic medicine as a conceptual paradigm for TME modulation in cancer, without original experimental data, clinical trials, or quantitative evidence of efficacy or safety.

SEP 7, 2026 · JOURNAL ARTICLE

Tissue-localized immunoengineering for in situ reprogramming of immune cells in cancer therapy

Discover Oncology

This is a narrative review proposing an emerging paradigm of tissue-localized immunoengineering; it raises conceptual and mechanistic questions rather than reporting original empirical evidence or clinical outcomes.